Summary by Futu AI
JD Health Co., Ltd. ("JD Health") will hold a board of directors meeting on Thursday, August 15, 2024 to review and announce the unaudited interim performance for the six months ended June 30, 2024, and consider whether to distribute interim dividends. At 6:00 pm on that day, the company's management will discuss the interim performance with investors through a teleconference, and provide dial-in numbers and participant passwords for global investors to participate. JD Health is led by Executive Director Jin Enlin, and includes non-executive directors Liu Qiangdong and Qingqing Yi, as well as digital independent non-executive directors.